Media release

AMA urges changes to the National Health Amendment (fifth community pharmacy agreement initiatives) Bill

The AMA has written to all MPs and Senators urging their support for changes to the National Health Amendment (Fifth Community Pharmacy Agreement Initiatives) Bill, which was introduced to Parliament yesterday.

AMA President, Dr Steve Hambleton, said today that the Bill in its current form would permit a significant change in the professional role of pharmacists that the AMA believes is not in the best interests of patients or the professional relationship between doctors and pharmacists.

“The Bill would allow pharmacists to dispense prescription medication without a valid prescription and without consulting a patient’s doctor beforehand,” Dr Hambleton said.

“The Pharmacy Guild of Australia calls this ‘continued dispensing’, a practice that is strongly opposed by the AMA.

“Only doctors are adequately trained to make assessments about a patient’s clinical condition and the need for medical treatment,” Dr Hambleton said.

Dr Hambleton said that doctors place a high value on the professional role of pharmacists.

“Our professions work together to improve the medication management of patients and their clinical outcomes.  But continued dispensing represents a breakdown in this collaborative team-based approach to patient care.

“A pharmacist has no way of knowing whether the patient’s doctor intends the patient to continue with a particular medication, to adjust it, or to cease that treatment.

“The medico-legal risks of continued dispensing for both pharmacists and doctors if an adverse medication event occurs have not been explored.

“Dispensing prescription medication without a prescription presents a fundamental conflict of interest – it allows the pharmacist to become both the prescriber and dispenser.”

Dr Hambleton said that there is a bizarre twist in the Bill.

“The Bill contains provisions that would require doctors to obtain an authority from Medicare clerks in order to prescribe additional repeats of oncology and palliative care medicines.  Yet, the Bill permits pharmacists to dispense prescription medicines without reference to anyone.

“There is no justification for the continued dispensing provisions of this Bill to be passed.  They are not in the best interests of patients.  The AMA will continue to lobby to have the Bill changed,” Dr Hambleton said.


24 November 2011

CONTACT:         John Flannery                       02 6270 5477 / 0419 494 761

                        Kirsty Waterford                   02 6270 5464 / 0427 209 753

Follow the AMA Media on Twitter: http://twitter.com/ama_media

Follow the AMA President on Twitter: http://twitter.com/amapresident

Media Contacts

Federal 

 02 6270 5478
 0427 209 753
 media@ama.com.au

Follow the AMA

 @ama_media
 @amapresident
‌ @AustralianMedicalAssociation